Literature DB >> 22858647

Complex regional pain syndrome following immunisation.

Stephanie Richards1, George Chalkiadis, Raman Lakshman, Jim P Buttery, Nigel W Crawford.   

Abstract

Complex regional pain syndrome type 1 (CRPS-1) is a clinical syndrome that affects one or more extremities and is characterised by persistent pain disproportionate to any inciting event, and at least one sign of autonomic dysfunction in the affected limb(s). The pathogenesis of this syndrome is poorly understood, but its onset is often precipitated by a physical injury, such as minor trauma, fracture, infection or a surgical procedure. In the literature, there are reports of CRPS-1 following immunisation with rubella and hepatitis B vaccines. Here we present a case series of CRPS-1 following immunisation in adolescents, with either diphtheria-tetanus-acellular pertussis (1 case), or human papillomavirus vaccines (4 cases). Enhanced awareness of this syndrome and its potential to occur following immunisation in the paediatric population is vital to the prompt and effective management of this condition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22858647     DOI: 10.1136/archdischild-2011-301307

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.

Authors:  Hazel J Clothier; Nigel W Crawford; Melissa Russell; Heath Kelly; Jim P Buttery
Journal:  Drug Saf       Date:  2017-06       Impact factor: 5.606

Review 2.  Autonomic dysfunction and HPV immunization: an overview.

Authors:  Svetlana Blitshteyn; Louise Brinth; Jeanne E Hendrickson; Manuel Martinez-Lavin
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

Review 3.  Serious adverse events after HPV vaccination: a critical review of randomized trials and post-marketing case series.

Authors:  Manuel Martínez-Lavín; Luis Amezcua-Guerra
Journal:  Clin Rheumatol       Date:  2017-07-20       Impact factor: 3.650

4.  Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome.

Authors:  Wen-Wu Li; Tian-Zhi Guo; Xiaoyou Shi; Eva Czirr; Trisha Stan; Peyman Sahbaie; Tony Wyss-Coray; Wade S Kingery; J David Clark
Journal:  Pain       Date:  2014-09-10       Impact factor: 6.961

5.  Adverse events following HPV immunization in Australia: Establishment of a clinical network.

Authors:  Nigel W Crawford; Kate Hodgson; Mike Gold; Jim Buttery; Nicholas Wood
Journal:  Hum Vaccin Immunother       Date:  2016-06-13       Impact factor: 3.452

Review 6.  Safety of human papillomavirus vaccines: a review.

Authors:  Kristine K Macartney; Clayton Chiu; Melina Georgousakis; Julia M L Brotherton
Journal:  Drug Saf       Date:  2013-06       Impact factor: 5.606

7.  Hazard of complex regional pain syndrome following human papillomavirus vaccination among adolescent girls in the United States: a case-cohort analysis of insurance claims data.

Authors:  Nadja A Vielot; Sylvia Becker-Dreps
Journal:  Expert Opin Drug Saf       Date:  2019-11-08       Impact factor: 4.250

Review 8.  Hypothesis: Human papillomavirus vaccination syndrome--small fiber neuropathy and dysautonomia could be its underlying pathogenesis.

Authors:  Manuel Martínez-Lavín
Journal:  Clin Rheumatol       Date:  2015-05-20       Impact factor: 3.650

9.  Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.

Authors:  Rotem Inbar; Ronen Weiss; Lucija Tomljenovic; Maria-Teresa Arango; Yael Deri; Christopher A Shaw; Joab Chapman; Miri Blank; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 4.505

10.  Investigating Reports of Complex Regional Pain Syndrome: An Analysis of HPV-16/18-Adjuvanted Vaccine Post-Licensure Data.

Authors:  Frank Huygen; Kristin Verschueren; Candida McCabe; Jens-Ulrich Stegmann; Julia Zima; Olivia Mahaux; Lionel Van Holle; Maria-Genalin Angelo
Journal:  EBioMedicine       Date:  2015-07-06       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.